Clinical differentiation Target healthcare providers and hospital systems focused on pediatric ENT diagnostics by highlighting the ultrasound-enabled otoscope’s objective, real-time data that differentiates bacterial from non-bacterial middle-ear fluid, potentially reducing unnecessary antibiotic prescriptions and improving patient outcomes.

Recurring revenue Leverage the device-plus-consumables model by promoting single-use ultrasound-enabled consumables tied to each patient exam, creating a predictable recurring revenue stream and increasing per-site visit profitability.

Regulatory momentum Position for opportunities with FDA clearance and engagement in regulatory programs (such as the FDA STeP program) to accelerate market access and build credibility with large healthcare organizations seeking compliant diagnostic innovations.

Strategic partnerships Explore collaborations with pediatric clinics, hospital systems, and university-affiliated medical centers to pilot in real-world workflows, generate clinical data, and accelerate adoption across ENT and primary care networks.

Market readiness Emphasize rapid integration into existing clinical workflows, portability, non-invasiveness, and familiar otoscope form factor to ease procurement discussions with procurement teams and drive faster decision cycles in mid-market to large hospital settings.